{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:32:18Z","timestamp":1792737138149,"version":"4.5.0"},"publisher-location":"Totowa, NJ","reference-count":59,"publisher":"Humana Press","isbn-type":[{"value":"9781617793455","type":"print"},{"value":"9781617793462","type":"electronic"}],"license":[{"start":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T00:00:00Z","timestamp":1315526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T00:00:00Z","timestamp":1315526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-1-61779-346-2_2","type":"book-chapter","created":{"date-parts":[[2011,10,12]],"date-time":"2011-10-12T17:03:44Z","timestamp":1318439024000},"page":"21-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Classification and Pathogenesis of Meningococcal Infections"],"prefix":"10.1007","author":[{"given":"Petter","family":"Brandtzaeg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"van Deuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,9]]},"reference":[{"issue":"Suppl 2","key":"2_CR1","doi-asserted-by":"publisher","first-page":"B64","DOI":"10.1016\/j.vaccine.2009.04.061","volume":"27","author":"DA Caugant","year":"2009","unstructured":"Caugant DA, Maiden MC (2009) Meningo-coccal carriage and disease-population biology and evolution. Vaccine 27 Suppl 2:B64\u2013B70","journal-title":"Vaccine"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrmicro2097","volume":"7","author":"M Virji","year":"2009","unstructured":"Virji M (2009) Pathogenic neisseriae: surface modulation, pathogenesis and infection control. Nat Rev Microbiol 7:274\u2013286","journal-title":"Nat Rev Microbiol"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/clinids\/13.1.22","volume":"13","author":"DS Stephens","year":"1991","unstructured":"Stephens DS, Farley MM (1991) Pathogenic events during infection of the human nasopharynx with Neisseria meningitidis and Haemophilus influenzae. Rev Infect Dis 13:22\u201333","journal-title":"Rev Infect Dis"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1084\/jem.17.5.553","volume":"17","author":"S Flexner","year":"1913","unstructured":"Flexner S (1913) The results of serum treatment in thirteen hundred cases of epidemic meningitis. J Exp Med 17:553\u2013576","journal-title":"J Exp Med"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1086\/504804","volume":"43","author":"R Brooks","year":"2006","unstructured":"Brooks R, Woods CW, Benjamin DK Jr et al (2006) Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. Clin Infect Dis 43:49\u201354","journal-title":"Clin Infect Dis"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s10096-008-0535-1","volume":"27","author":"SC de Greeff","year":"2008","unstructured":"de Greeff SC, de Melker HE, Schouls LM et al (2008) Pre-admission clinical course of meningococcal disease and opportunities for the earlier start of appropriate intervention: a prospective epidemiological study on 752 patients in the Netherlands, 2003-2005. Eur J Clin Microbiol Infect Dis 27:985\u2013992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1086\/315158","volume":"180","author":"NE Rosenstein","year":"1999","unstructured":"Rosenstein NE, Perkins BA, Stephens DS et al (1999) The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 180:1894\u20131901","journal-title":"J Infect Dis"},{"key":"2_CR8","first-page":"155","volume":"6","author":"TW Gedde-Dahl","year":"1983","unstructured":"Gedde-Dahl TW, Hoiby EA, Schillinger A et al (1983) An epidemiological, clinical and microbiological follow-up study of incident meningococcal disease cases in Norway, winter 1981-1982. Material and epidemiology in the MenOPP project. NIPH Ann 6:155\u2013168","journal-title":"NIPH Ann"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/00365548709032375","volume":"19","author":"A Halstensen","year":"1987","unstructured":"Halstensen A, Pedersen SH, Haneberg B et al (1987) Case fatality of meningococcal disease in western Norway. Scand J Infect Dis 19:35\u201342","journal-title":"Scand J Infect Dis"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/infdis\/159.2.195","volume":"159","author":"P Brandtzaeg","year":"1989","unstructured":"Brandtzaeg P, Kierulf P, Gaustad P et al (1989) Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 159:195\u2013204","journal-title":"J Infect Dis"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1128\/CMR.13.1.144","volume":"13","author":"M van Deuren","year":"2000","unstructured":"van Deuren M, Brandtzaeg P, van der Meer JW (2000) Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 13:144\u201366","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 1","key":"2_CR12","doi-asserted-by":"publisher","first-page":"A24","DOI":"10.1016\/j.vaccine.2007.04.036","volume":"25","author":"P Boisier","year":"2007","unstructured":"Boisier P, Mainassara HB, Sidikou F et al (2007) Case-fatality ratio of bacterial meningitis in the African meningitis belt: we can do better. Vaccine 25 Suppl 1:A24\u2013A29","journal-title":"Vaccine"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","volume":"344","author":"NE Rosenstein","year":"2001","unstructured":"Rosenstein NE, Perkins BA, Stephens DS et al (2001) Meningococcal disease. N Engl J Med 344:1378\u20131388","journal-title":"N Engl J Med"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","volume":"369","author":"DS Stephens","year":"2007","unstructured":"Stephens DS, Greenwood B, Brandtzaeg P (2007) Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369:2196\u20132210","journal-title":"Lancet"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/ng.640","volume":"42","author":"S Davila","year":"2010","unstructured":"Davila S, Wright VJ, Khor CC et al (2010) Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat Genet 42:772\u2013776","journal-title":"Nat Genet"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1080\/00365540600643203","volume":"38","author":"E Haralambous","year":"2006","unstructured":"Haralambous E, Dolly SO, Hibberd ML et al (2006) Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients. Scand J Infect Dis 38:764\u2013771","journal-title":"Scand J Infect Dis"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S1473-3099(10)70045-1","volume":"10","author":"MC Brouwer","year":"2010","unstructured":"Brouwer MC, Read RC, van de Beek D (2010) Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis 10:262\u2013274","journal-title":"Lancet Infect Dis"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0022-3476(66)80250-0","volume":"68","author":"ER Stiehm","year":"1966","unstructured":"Stiehm ER, Damrosch DS (1966) Factors in the prognosis of meningococcal infection. Review of 63 cases with emphasis on recognition and management of the severely ill patient. J Pediatr 68:457\u2013467","journal-title":"J Pediatr"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/3527608508.ch21","volume-title":"Handbook of meningococcal disease","author":"P Brandtzaeg","year":"2006","unstructured":"Brandtzaeg P (2006) Pathogenesis and pathophysiology of invasive meningococcal disease. In: Frosch M, Maiden CJ (eds) Handbook of meningococcal disease. Wiley-VCH, Weinheim, pp 427\u2013480"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/med\/9780199204854.003.070605_update_004","volume-title":"Oxford Textbook of Medicine","author":"P Brandtzaeg","year":"2010","unstructured":"Brandtzaeg P (2010) Meningococcal Infections. In: Warrell DA, Cox TM, Firth JD (eds) Oxford Textbook of Medicine, 5th edn. Oxford University Press, Oxford, pp 709\u2013722","edition":"5"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/adc.86.1.44","volume":"86","author":"SJ Hackett","year":"2002","unstructured":"Hackett SJ, Guiver M, Marsh J et al (2002) Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child 86:44\u201346","journal-title":"Arch Dis Child"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1086\/596707","volume":"48","author":"T Darton","year":"2009","unstructured":"Darton T, Guiver M, Naylor S et al (2009) Severity of meningococcal disease associated with genomic bacterial load. Clin Infect Dis 48:587\u2013594","journal-title":"Clin Infect Dis"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1128\/JCM.42.7.2980-2987.2004","volume":"42","author":"R Ovstebo","year":"2004","unstructured":"Ovstebo R, Brandtzaeg P, Brusletto B et al (2004) Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J Clin Microbiol 42:2980\u20132987","journal-title":"J Clin Microbiol"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.1128\/IAI.70.9.5193-5201.2002","volume":"70","author":"OB Harrison","year":"2002","unstructured":"Harrison OB, Robertson BD, Faust SN et al (2002) Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo. Infect Immun 70:5193\u20135201","journal-title":"Infect Immun"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1136\/bmj.306.6887.1229","volume":"306","author":"M van Deuren","year":"1993","unstructured":"van Deuren M, van Dijke BJ, Koopman RJ et al (1993) Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ 306:1229\u20131232","journal-title":"BMJ"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1097\/01.CCM.0000174482.51523.96","volume":"33","author":"M van Deuren","year":"2005","unstructured":"van Deuren M, Brandtzaeg P (2005) Myocardial dysfunction in meningococcal septic shock: no clear answer yet. Crit Care Med 33:1884\u20131886","journal-title":"Crit Care Med"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1097\/00003246-199906000-00050","volume":"27","author":"PB Baines","year":"1999","unstructured":"Baines PB, Stanford S, Bishop-Bailey D et al (1999) Nitric oxide production in meningococcal disease is directly related to disease severity. Crit Care Med 27:1187\u20131190","journal-title":"Crit Care Med"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/09680519000060060501","volume":"6","author":"A Bjerre","year":"2000","unstructured":"Bjerre A, Brusletto B, Rosenqvist E et al (2000) Cellular activating properties and morphology of membrane-bound and purified meningococcal lipopolysaccharide. J Endotoxin Res 6:437\u2013445","journal-title":"J Endotoxin Res"},{"key":"2_CR29","first-page":"401","volume":"7","author":"P Brandtzaeg","year":"2001","unstructured":"Brandtzaeg P, Bjerre A, Ovstebo R et al (2001) Neisseria meningitidis lipopolysaccharides in human pathology. J Endotoxin Res 7:401\u2013420","journal-title":"J Endotoxin Res"},{"key":"2_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/09680519030090030301","volume":"9","author":"A Bjerre","year":"2003","unstructured":"Bjerre A, Brusletto B, Ovstebo R et al (2003) Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex. J Endotoxin Res 9:155\u2013163","journal-title":"J Endotoxin Res"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1128\/IAI.00195-08","volume":"76","author":"BC Hellerud","year":"2008","unstructured":"Hellerud BC, Stenvik J, Espevik T et al (2008) Stages of meningococcal sepsis simulated in vitro, with emphasis on complement and Toll-like receptor activation. Infect Immun 76:4183\u20134189","journal-title":"Infect Immun"},{"key":"2_CR32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1189\/jlb.70.2.283","volume":"70","author":"T Sprong","year":"2001","unstructured":"Sprong T, Stikkelbroeck N, van der Ley P et al (2001) Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response. J Leukoc Biol 70:283\u2013288","journal-title":"J Leukoc Biol"},{"key":"2_CR33","doi-asserted-by":"publisher","first-page":"41702","DOI":"10.1074\/jbc.M307198200","volume":"278","author":"SE Girardin","year":"2003","unstructured":"Girardin SE, Travassos LH, Herve M et al (2003) Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem 278:41702\u201341708","journal-title":"J Biol Chem"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1128\/IAI.69.4.2230-2236.2001","volume":"69","author":"RR Ingalls","year":"2001","unstructured":"Ingalls RR, Lien E, Golenbock DT (2001) Membrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through toll-like receptor 2. Infect Immun 69:2230\u20132236","journal-title":"Infect Immun"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0966-842X(02)00037-9","volume":"11","author":"P Massari","year":"2003","unstructured":"Massari P, Ram S, Macleod H et al (2003) The role of porins in neisserial pathogenesis and immunity. Trends Microbiol 11:87\u201393","journal-title":"Trends Microbiol"},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1189\/jlb.1105626","volume":"80","author":"TH Mogensen","year":"2006","unstructured":"Mogensen TH, Paludan SR, Kilian M et al (2006) Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J Leukoc Biol 80:267\u2013277","journal-title":"J Leukoc Biol"},{"key":"2_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1086\/317647","volume":"183","author":"AC Pridmore","year":"2001","unstructured":"Pridmore AC, Wyllie DH, Abdillahi F et al (2001) A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but not via TLR4\/MD2. J Infect Dis 183:89\u201396","journal-title":"J Infect Dis"},{"key":"2_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/10408419891294216","volume":"24","author":"CM Kahler","year":"1998","unstructured":"Kahler CM, Stephens DS (1998) Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin). Crit Rev Microbiol 24:281\u2013334","journal-title":"Crit Rev Microbiol"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1128\/jb.174.6.1793-1800.1992","volume":"174","author":"VA Kulshin","year":"1992","unstructured":"Kulshin VA, Zahringer U, Lindner B et al (1992) Structural characterization of the lipid A component of pathogenic Neisseria meningitidis. J Bacteriol 174:1793\u20131800","journal-title":"J Bacteriol"},{"key":"2_CR40","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.vaccine.2005.09.039","volume":"24","author":"S Zughaier","year":"2006","unstructured":"Zughaier S, Agrawal S, Stephens DS et al (2006) Hexa-acylation and KDO(2)-glycosylation determine the specific immunostimulatory activity of Neisseria meningitidis lipid A for human monocyte derived dendritic cells. Vaccine 24:1291\u20131297","journal-title":"Vaccine"},{"key":"2_CR41","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1099\/00222615-41-4-236","volume":"41","author":"RJ Scholten","year":"1994","unstructured":"Scholten RJ, Kuipers B, Valkenburg HA et al (1994) Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies. J Med Microbiol 41:236\u2013243","journal-title":"J Med Microbiol"},{"key":"2_CR42","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1128\/IAI.69.10.5981-5990.2001","volume":"69","author":"P van der Ley","year":"2001","unstructured":"van der Ley P, Steeghs L, Hamstra HJ et al (2001) Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. Infect Immun 69:5981\u20135990","journal-title":"Infect Immun"},{"key":"2_CR43","doi-asserted-by":"publisher","first-page":"e1000396","DOI":"10.1371\/journal.ppat.1000396","volume":"5","author":"F Fransen","year":"2009","unstructured":"Fransen F, Heckenberg SG, Hamstra HJ et al (2009) Naturally occurring lipid A mutants in Neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLoS Pathog 5:e1000396","journal-title":"PLoS Pathog"},{"key":"2_CR44","doi-asserted-by":"publisher","first-page":"21515","DOI":"10.1074\/jbc.M109.004887","volume":"284","author":"CM John","year":"2009","unstructured":"John CM, Liu M, Jarvis GA (2009) Natural phosphoryl and acyl variants of lipid A from Neisseria meningitidis strain 89I differentially induce tumor necrosis factor-alpha in human monocytes. J Biol Chem 284:21515\u201321525","journal-title":"J Biol Chem"},{"key":"2_CR45","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/chem.200701165","volume":"14","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Gaekwad J, Wolfert MA et al (2008) Innate immune responses of synthetic lipid A derivatives of Neisseria meningitidis. Chemistry 14:558\u2013569","journal-title":"Chemistry"},{"key":"2_CR46","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/glycob\/cwm057","volume":"17","author":"SM Zimmer","year":"2007","unstructured":"Zimmer SM, Zughaier SM, Tzeng YL et al (2007) Human MD-2 discrimination of meningococcal lipid A structures and activation of TLR4. Glycobiology 17:847\u2013856","journal-title":"Glycobiology"},{"key":"2_CR47","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/33046","volume":"392","author":"L Steeghs","year":"1998","unstructured":"Steeghs L, den Hartog R, den Boer A et al (1998) Meningitis bacterium is viable without endotoxin. Nature 392:449\u2013450","journal-title":"Nature"},{"key":"2_CR48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1128\/IAI.71.1.155-162.2003","volume":"71","author":"B Albiger","year":"2003","unstructured":"Albiger B, Johansson L, Jonsson AB (2003) Lipooligosaccharide-deficient Neisseria meningitidis shows altered pilus-associated characteristics. Infect Immun 71:155\u2013162","journal-title":"Infect Immun"},{"key":"2_CR49","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1586\/14787210.1.4.589","volume":"1","author":"P Brandtzaeg","year":"2003","unstructured":"Brandtzaeg P (2003) Host response to Neisseria meningitidis lacking lipopolysaccharides. Expert Rev Anti Infect Ther 1:589\u2013596","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2_CR50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/infdis\/160.1.58","volume":"160","author":"P Brandtzaeg","year":"1989","unstructured":"Brandtzaeg P, Mollnes TE, Kierulf P (1989) Complement activation and endotoxin levels in systemic meningococcal disease. J Infect Dis 160:58\u201365","journal-title":"J Infect Dis"},{"key":"2_CR51","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1086\/338269","volume":"185","author":"A Bjerre","year":"2002","unstructured":"Bjerre A, Brusletto B, Mollnes TE et al (2002) Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant. J Infect Dis 185:220\u2013228","journal-title":"J Infect Dis"},{"key":"2_CR52","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1128\/IAI.01625-07","volume":"76","author":"R Ovstebo","year":"2008","unstructured":"Ovstebo R, Olstad OK, Brusletto B et al (2008) Identification of genes particularly sensitive to lipopolysaccharide (LPS) in human monocytes induced by wild-type versus LPS-deficient Neisseria meningitidis strains. Infect Immun 76:2685\u20132695","journal-title":"Infect Immun"},{"key":"2_CR53","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1128\/IAI.01508-06","volume":"75","author":"A Schubert-Unkmeir","year":"2007","unstructured":"Schubert-Unkmeir A, Sokolova O, Panzner U et al (2007) Gene expression pattern in human brain endothelial cells in response to Neisseria meningitidis. Infect Immun 75:899\u2013914","journal-title":"Infect Immun"},{"key":"2_CR54","first-page":"1","volume-title":"Emerging strategies in the fight against meningitis: molecular and cellular aspects","author":"M Christodoulides","year":"2002","unstructured":"Christodoulides M, Heckels JE, Weller RO (2002). The role of the leptomeninges in meningococcal meningitis. In: Ferreiros C, Criado MT, and Vavquez J (eds) Emerging strategies in the fight against meningitis: molecular and cellular aspects. Horizon Scientific Press, Norfolk: pp1\u201334"},{"key":"2_CR55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.pneurobio.2009.12.004","volume":"91","author":"O Join-Lambert","year":"2010","unstructured":"Join-Lambert O, Morand PC, Carbonnelle E et al (2010) Mechanisms of meningeal invasion by a bacterial extracellular pathogen, the example of Neisseria meningitidis. Prog Neurobiol 91:130\u2013139","journal-title":"Prog Neurobiol"},{"key":"2_CR56","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1128\/IAI.69.4.2718-2722.2001","volume":"69","author":"DB Wells","year":"2001","unstructured":"Wells DB, Tighe PJ, Wooldridge KG et al (2001) Differential gene expression during meningeal-meningococcal interaction: evidence for self-defense and early release of cytokines and chemokines. Infect Immun 69:2718\u20132722","journal-title":"Infect Immun"},{"key":"2_CR57","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1128\/IAI.73.5.2940-2950.2005","volume":"73","author":"SM Zughaier","year":"2005","unstructured":"Zughaier SM, Zimmer SM, Datta A et al (2005) Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect Immun 73:2940\u20132950","journal-title":"Infect Immun"},{"key":"2_CR58","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/SHK.0b013e31819c37be","volume":"32","author":"EW Nielsen","year":"2009","unstructured":"Nielsen EW, Hellerud BC, Thorgersen EB et al (2009) A new dynamic porcine model of meningococcal shock. Shock 32:302\u2013309","journal-title":"Shock"},{"key":"2_CR59","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1097\/CCM.0b013e3181de8c94","volume":"38","author":"BC Hellerud","year":"2010","unstructured":"Hellerud BC, Nielsen EW, Thorgersen EB et al (2010) Dissecting the effects of lipopolysaccharides from nonlipopolysaccharide molecules in experimental porcine meningococcal sepsis. Crit Care Med 38:1467\u20131474","journal-title":"Crit Care Med"}],"container-title":["Methods in Molecular Biology","Neisseria meningitidis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-61779-346-2_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T12:10:23Z","timestamp":1686399023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-61779-346-2_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,9]]},"ISBN":["9781617793455","9781617793462"],"references-count":59,"URL":"https:\/\/doi.org\/10.1007\/978-1-61779-346-2_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,9]]},"assertion":[{"value":"9 September 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}